Mechanism of M2 macrophages modulating astrocyte polarization through the TGF-β/PI3K/Akt pathway

Qi-Ming Pang1, Qian Zhang2, Xiang-Chong Wu3

  • 1Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China; Department of Orthopaedic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China; Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Immunology Letters
|May 27, 2023
PubMed

Insights

Transforming astrocytes (AS) into a neuroprotective A2 phenotype is crucial for spinal cord injury repair. This study reveals that TGF-β from M2 macrophages activates the PI3K/Akt pathway, driving A2 astrocyte polarization.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Activated astrocytes (AS) differentiate into A1 and A2 phenotypes.
  • A2 astrocytes are vital for neuroprotection and tissue repair after spinal cord injury.
  • The precise mechanisms governing A2 astrocyte polarization are not fully understood.

Purpose of the Study:

  • To investigate if TGF-β secreted by M2 macrophages can induce A2 astrocyte polarization.
  • To determine the role of the PI3K/Akt pathway in M2 macrophage-mediated A2 astrocyte polarization.

Main Methods:

  • Co-culture of M2 macrophages and astrocytes.
  • Treatment with M2 macrophage-conditioned medium (M2-CM).
  • Inhibition of TGF-β receptor (SB431542) and PI3K (LY294002).
  • Immunofluorescence staining for A2 biomarker S100A10.
  • Western blot analysis for PI3K/Akt pathway activation.

Main Results:

  • M2 macrophages and M2-CM promoted IL-10, IL-13, and TGF-β secretion from AS.
  • Inhibition of TGF-β or PI3K reversed these effects.
  • TGF-β from M2 macrophages increased S100A10 expression in AS.
  • This process involved the activation of the PI3K/Akt pathway in AS.

Conclusions:

  • TGF-β secreted by M2 macrophages induces A2 astrocyte polarization.
  • The PI3K/Akt pathway is a key mediator in this M2 macrophage-driven astrocyte reprogramming.
  • This finding offers potential therapeutic targets for spinal cord injury.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K